Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: OTC BB
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Titan Pharmaceuticals Inc

+ Add to Watchlist

TTNP:US

0.6600 USD 0.0100 1.49%

As of 20:10:06 ET on 03/04/2015.

Snapshot for Titan Pharmaceuticals Inc (TTNP)

Open: 0.6700 Day's Range: 0.6522 - 0.6700 Volume: 253,698
Previous Close: 0.6700 52wk Range: 0.4400 - 0.8650 1-Yr Rtn: -4.35%

Stock Chart for TTNP

No chart data available.
  • TTNP:US 0.6600
  • 1D
  • 1M
  • 1Y
0.6700
Interactive TTNP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for TTNP

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.0400
Est. EPS (USD) (12/2014) -0.0300
Est. PEG Ratio -
Market Cap (M USD) 72.60
Shares Outstanding (M) 110.00
30 Day Average Volume 598,315
Price/Book (mrq) 17.0783
Price/Sale (ttm) 15.9284
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/31/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for TTNP

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for TTNP

Titan Pharmaceuticals, Inc. is a biopharmaceutical company that develops proprietary therapeutics for the treatment of central nervous system disorders, cancer, and other serious and life threatening diseases. The company is also developing gene therapy and drug delivery technologies.

Marc RubinChairmanSunil BhonslePresident/CFO
Katherine Glassman-BeebeExec VP/Chief Development Officer
More Company Profile & Key Executives for TTNP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil